CPRX logo

Catalyst Pharmaceuticals (CPRX) Total liabilities

annual total liabilities:

$123.78M+$41.55M(+50.52%)
December 31, 2024

Summary

  • As of today (June 28, 2025), CPRX annual total liabilities is $123.78 million, with the most recent change of +$41.55 million (+50.52%) on December 31, 2024.
  • During the last 3 years, CPRX annual total liabilities has risen by +$92.82 million (+299.84%).
  • CPRX annual total liabilities is now at all-time high.

Performance

CPRX Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

quarterly total liabilities:

$114.59M-$9.19M(-7.42%)
March 31, 2025

Summary

  • As of today (June 28, 2025), CPRX quarterly total liabilities is $114.59 million, with the most recent change of -$9.19 million (-7.42%) on March 31, 2025.
  • Over the past year, CPRX quarterly total liabilities has increased by +$29.32 million (+34.39%).
  • CPRX quarterly total liabilities is now -7.42% below its all-time high of $123.78 million, reached on December 31, 2024.

Performance

CPRX quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

CPRX Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+50.5%+34.4%
3 y3 years+299.8%+328.4%
5 y5 years+400.2%+529.5%

CPRX Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+299.8%-7.4%+337.1%
5 y5-yearat high+443.9%-7.4%+529.5%
alltimeall timeat high>+9999.0%-7.4%>+9999.0%

CPRX Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$114.59M(-7.4%)
Dec 2024
$123.78M(+50.5%)
$123.78M(+11.4%)
Sep 2024
-
$111.07M(+13.7%)
Jun 2024
-
$97.70M(+14.6%)
Mar 2024
-
$85.26M(+3.7%)
Dec 2023
$82.23M(+9.3%)
$82.23M(+27.2%)
Sep 2023
-
$64.66M(-5.7%)
Jun 2023
-
$68.60M(-6.7%)
Mar 2023
-
$73.57M(-2.2%)
Dec 2022
$75.21M(+142.9%)
$75.21M(+19.2%)
Sep 2022
-
$63.07M(+140.6%)
Jun 2022
-
$26.22M(-2.0%)
Mar 2022
-
$26.75M(-13.6%)
Dec 2021
$30.96M(+36.0%)
$30.96M(+25.9%)
Sep 2021
-
$24.59M(+21.8%)
Jun 2021
-
$20.19M(+8.7%)
Mar 2021
-
$18.57M(-18.4%)
Dec 2020
$22.76M(-8.0%)
$22.76M(+24.8%)
Sep 2020
-
$18.23M(-9.8%)
Jun 2020
-
$20.21M(+11.0%)
Mar 2020
-
$18.20M(-26.4%)
Dec 2019
$24.75M(+156.0%)
$24.75M(+32.3%)
Sep 2019
-
$18.71M(+25.1%)
Jun 2019
-
$14.95M(+51.0%)
Mar 2019
-
$9.90M(+2.4%)
Dec 2018
$9.67M(+118.5%)
$9.67M(+166.1%)
Sep 2018
-
$3.63M(+12.6%)
Jun 2018
-
$3.23M(+11.9%)
Mar 2018
-
$2.88M(-34.9%)
Dec 2017
$4.42M(+84.5%)
$4.42M(+52.4%)
Sep 2017
-
$2.90M(+44.3%)
Jun 2017
-
$2.01M(-22.7%)
Mar 2017
-
$2.60M(+8.5%)
Dec 2016
$2.40M(-48.2%)
$2.40M(-0.5%)
Sep 2016
-
$2.41M(-7.9%)
Jun 2016
-
$2.62M(-16.4%)
Mar 2016
-
$3.13M(-32.3%)
Dec 2015
$4.63M
$4.63M(+18.2%)
Sep 2015
-
$3.91M(-29.4%)
DateAnnualQuarterly
Jun 2015
-
$5.54M(-41.2%)
Mar 2015
-
$9.43M(+8.8%)
Dec 2014
$8.67M(+117.8%)
$8.67M(-6.0%)
Sep 2014
-
$9.22M(+94.5%)
Jun 2014
-
$4.74M(+3.3%)
Mar 2014
-
$4.59M(+15.4%)
Dec 2013
$3.98M(+83.6%)
$3.98M(-39.5%)
Sep 2013
-
$6.58M(+143.5%)
Jun 2013
-
$2.70M(+74.4%)
Mar 2013
-
$1.55M(-28.5%)
Dec 2012
$2.17M(-12.9%)
$2.17M(-20.0%)
Sep 2012
-
$2.71M(+109.6%)
Jun 2012
-
$1.29M(-43.1%)
Mar 2012
-
$2.27M(-8.7%)
Dec 2011
$2.49M(+693.3%)
$2.49M(+488.7%)
Sep 2011
-
$422.70K(-35.6%)
Jun 2011
-
$656.10K(-24.9%)
Mar 2011
-
$873.10K(+178.3%)
Dec 2010
$313.70K(-10.0%)
$313.70K(-24.4%)
Sep 2010
-
$414.80K(-16.8%)
Jun 2010
-
$498.60K(+30.7%)
Mar 2010
-
$381.40K(+9.4%)
Dec 2009
$348.50K(-76.3%)
$348.50K(+10.5%)
Sep 2009
-
$315.30K(-37.9%)
Jun 2009
-
$507.40K(-67.8%)
Mar 2009
-
$1.58M(+7.0%)
Dec 2008
$1.47M(+312.3%)
$1.47M(+16.3%)
Sep 2008
-
$1.27M(+60.5%)
Jun 2008
-
$788.90K(+61.3%)
Mar 2008
-
$489.10K(+36.9%)
Dec 2007
$357.20K(-53.8%)
$357.20K(-11.8%)
Sep 2007
-
$405.10K(-3.2%)
Jun 2007
-
$418.50K(-20.2%)
Mar 2007
-
$524.30K(-32.2%)
Dec 2006
$772.80K(+125.3%)
$772.80K(+12.6%)
Sep 2006
-
$686.50K(+58.0%)
Jun 2006
-
$434.40K(+26.6%)
Dec 2005
$343.00K(+405.9%)
$343.00K(+405.9%)
Dec 2004
$67.80K(+1.6%)
$67.80K
Dec 2002
$66.70K
-

FAQ

  • What is Catalyst Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals annual total liabilities year-on-year change?
  • What is Catalyst Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals quarterly total liabilities year-on-year change?

What is Catalyst Pharmaceuticals annual total liabilities?

The current annual total liabilities of CPRX is $123.78M

What is the all time high annual total liabilities for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high annual total liabilities is $123.78M

What is Catalyst Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, CPRX annual total liabilities has changed by +$41.55M (+50.52%)

What is Catalyst Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of CPRX is $114.59M

What is the all time high quarterly total liabilities for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high quarterly total liabilities is $123.78M

What is Catalyst Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, CPRX quarterly total liabilities has changed by +$29.32M (+34.39%)
On this page